HillSignal

Company

REVVITY, INC. $RVTY

Signals and chartPatents, raises and connections

Federal figures from USAspending, gathered Oct 25, 2026.

SEC revenue and federal obligations

SEC revenue, 12 months to Jul 5, 2026
$2.9B
10-Q, filed Aug 11, 2026
Federal contract obligations, same 12 months (Jul 2025 to Jun 2026)
$4.7M
Contract obligations vs revenue
0.16%
A guide, not a revenue split. Subcontracts and classified work are not included: see the note below.
Contracts obligated, federal fiscal yearCompany revenue, its fiscal year ending in that year (10-K)
  • FY2026
    Oct 2025 to Sep 2026
    $5.4M
    $2.9B year to Dec 28, 2025
  • FY2025
    Oct 2024 to Sep 2025
    $5.4M
    $2.8B year to Dec 29, 2024
  • FY2024
    Oct 2023 to Sep 2024
    $14.4M
    $2.8B year to Dec 31, 2023
  • FY2023
    Oct 2022 to Sep 2023
    $7.9M
    Revenue for this year not on file
  • FY2022
    Oct 2021 to Sep 2022
    $11.5M
    Revenue for this year not on file
What these numbers are

Obligated means an agency committed the money to this company in that period (a signed contract action), as reported to USAspending. It is not a payment and not revenue: a contract can be funded for several years at once, and revenue is booked as the work is done. Some years can exceed revenue for that reason.

Prime contracts only, and only what is published. Work the company does as a subcontractor is not in these figures, and classified contracts are not published on USAspending at all. A low share can mean either. Contract values, ceilings and options are never added in.

Which units count: the USAspending recipient that is the company's SEC registrant; units of the company that USAspending's own records place under it (as parent, or in its family tree); and subsidiaries from the company's SEC Exhibit 21 that carry its name. Joint ventures, units now owned by someone else, and records that only share a name are held back. Both lists are below.

Earlier years count the units the company owns today. A unit we checked by hand (its USAspending parent is out of date) counts from the date the company bought it, or, where no filing gives that date, from the first date a filing shows the company owning it. Other units count for every year shown until their purchase dates are loaded.

Revenue bars are the company's own fiscal year from its 10-K, placed in the federal year it ends in; its fiscal year can end in a different month than the government's.

Fiscal year 2022 onward. Federal fiscal years run October to September; the company's own fiscal year may differ.

Units counted (12), held back (19)

Held back: a matching name we could not tie to this company firmly enough. A miss is better than a wrong link.

  • ADVANCED CHEMISTRY DEVELOPMENT INC (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
  • EUROIMMUN US INC (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
  • HORIZON DISCOVERY BIOSCIENCES LIMITED (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
  • EUROIMMUN US INC (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
  • OMNI INTERNATIONAL INCORPORATED (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
  • OMNI INTERNATIONAL INC (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
  • EUROIMMUN US INC (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
  • SAGE LABS, INC. (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
  • ADVANCED CHEMISTRY DEVELOPMENT INC (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
  • OXFORD IMMUNOTEC LTD (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
  • OMNI INTERNATIONAL INC. (an old record with no UEI whose name is not exactly the company's SEC name)
  • NOVASCREEN BIOSCIENCES CORPORATION (USAspending's current parent is CALIPER LIFE SCIENCES, INC., not this company)
  • OPTIMIZATION ZORN CORPORATION (an old record with no UEI whose name is not exactly the company's SEC name)
  • OMNI INTERNATIONAL CORPORATION (an old record with no UEI whose name is not exactly the company's SEC name)
  • CAMBRIDGE RESEARCH & INSTRUMENTATION, INC. (USAspending's current parent is CALIPER LIFE SCIENCES, INC., not this company)
  • OMNI INTERNATIONAL LLC (Exhibit 21 subsidiary, and USAspending lists no parent of ours)
  • SAGE LABS INC (an old record with no UEI whose name is not exactly the company's SEC name)
  • OMNI INTERNATIONAL LLC (an old record with no UEI whose name is not exactly the company's SEC name)
  • IMMUNODIAGNOSTIC SYSTEMS INC (an old record with no UEI whose name is not exactly the company's SEC name)

Top agencies, contracts obligated in FY2026

  • Department of Health and Human Services$3.9M
  • Department of Defense$881K
  • Department of Veterans Affairs$253K
  • Department of Homeland Security$96K
  • Environmental Protection Agency$75K
  • Department of the Interior$74K
  • Department of Energy$68K
  • Department of Commerce$63K

Largest contracts active in the last 12 months

Amount: obligated to date on the contract, all years. Ranked by that amount among contracts with any action in the last 12 months. Counts only consolidated subsidiaries.

Lobbying

10 filings, 2024 to 2026. In-house lobbying spend $485K.

Firms: Revvity, Inc.

Issues: Health Issues, Medical/Disease Research/Clinical Labs, Trade (domestic/foreign)

Contacted: Senate, House Of Representatives, Health & Human Services, Dept Of (Hhs), Bureau Of Industry And Security (Bis)

Revolving door: 1 lobbyist held government posts
  • Jordan Cox Revvity, Inc. · last filed 2024
    Sr. Advisor, Office of the Asst Secretary for Legislation, US Dept. of Health & Human Services, Sr. Legislative Asst, US Representative Vicky Hartzler, Legislative Aide, US Senator Deb Fischer, Legislative Aide, US Representative John R. Carter

Former posts as each lobbyist listed them ("covered position") on the company's Senate LDA filings.

From the company's Senate LDA filings. Firm fees and in-house spend are reported on different filings, so they are shown apart. Lobbying is legal and common; it shows what the company paid to be heard on, not what it got.

PAC giving

Revvity Inc. Pac (Revvity Pac)
  • Katherine M. Clark House, MA$5K
  • Seth Moulton House, MA$2K
  • Bill Cassidy Senate, LA$1K

The company's own PAC (linked by the connected organization on its FEC Form 1). Top candidates it gave to, all cycles we hold, from the candidates' own FEC reports; tracked candidates only, so not a complete total.

Contracts ending in the next 18 months

None in the contracts we hold for this company.

Amount: obligated to date. From the contracts in HillSignal's records tied to this ticker; the full list of contracts ending across government is on Recompetes.

Insider trades

Bought, last 12 months
$0
0 trades
Sold, last 12 months
$1.7M
6 trades
Sells under a 10b5-1 plan
100%
4 of 4 sells whose filing has the plan box; 2 not read yet
Largest trade
$1.0M
Sold by Vohra Tajinder S, Sep 16, 2026

Open-market buys and sells from SEC Form 4 filings; grants and option exercises left out, and trades whose filed price failed our market check. A 10b5-1 plan is a trading schedule set in advance, so those sells say little about the insider's view. The plan box is on filings from April 2023 on.